Abstract
The objective of this chapter is to consider widely held popular beliefs surrounding UTIs and to see whether they stand up when scrutinized by medical research.
A great deal has been written on the subject of cranberry juice and its role in the treatment and prevention of UTIs. Cranberry juice can help prevent recurrent UTIs in women, but there is no evidence that it is effective in treating UTIs. Cranberry products work by inhibiting pathogenic adherence to the uroepithelium and probably not through acidification of the urine as was previously thought. Uva ursi (bearberry) can be used to treat UTIs affecting the lower tract, but should not be used for long-term prophylaxis as prolonged exposure to metabolites may be carcinogenic.
There is some weak evidence to suggest that probiotics and some vitamins (e.g., vitamin C) can help prevent UTIs. In addition to this, there is an association between frequency of sexual intercourse and UTIs, but not between number of partners and UTIs. Bubble bath probably does not increase the risk of UTIs, whereas condom use and contraceptive diaphragm use are associated with higher rates of UTI, although this should not discourage the use of safe sex.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008;(1):CD001321.
Cernakova M, Kostalova D. Antimicrobial activity of berberine – a constituent of Mahonia aquifolium. Folia Microbiol (Praha). 2002;47(4):375–8.
Ofek I, Goldhar J, Zafriri D, Lis H, Adar R, Sharon N. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. N Engl J Med. 1991;324(22):1599.
Schindler G, Patzak U, Brinkhaus B, von Niecieck A, Wittig J, Krahmer N, Glockl I, Veit M. Urinary excretion and metabolism of arbutin after oral administration of Arctostaphylos uvae ursi extract as film-coated tablets and aqueous solution in healthy humans. J Clin Pharmacol. 2002;42(8):920–7.
Ochoa-Brust GJ, Fernandez AR, Villanueva-Ruiz GJ, Velasco R, Trujillo-Hernandez B, Vasquez C. Daily intake of 100 mg ascorbic acid as urinary tract infection prophylactic agent during pregnancy. Acta Obstet Gynecol Scand. 2007;86(7):783–7.
Schaeffer AJ, Chmiel JS, Duncan JL, Falkowski WS. Mannose-sensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J Urol. 1984;131(5):906–10.
Borchert D, Sheridan L, Papatsoris A, Faruquz Z, Barua JM, Junaid I, Pati Y, Chinegwundoh F, Buchholz N. Prevention and treatment of urinary tract infection with probiotics: review and research perspective. Indian J Urol. 2008;24(2):139–44.
de Vrese M. Health benefits of probiotics and prebiotics in women. Menopause Int. 2009;15(1):35–40.
Jepson RG, Mihaljevic L, Craig J. Cranberries for treating urinary tract infections. Cochrane Database Syst Rev 2000;(2):CD001322.
Griffiths P. The role of cranberry juice in the treatment of urinary tract infections. Br J Community Nurs. 2003;8(12):557–61.
Santillo VM, Lowe FC. Cranberry juice for the prevention and treatment of urinary tract infections. Drugs Today (Barc). 2007;43(1):47–54.
Sumukadas D, Davey P, McMurdo ME. Recurrent urinary tract infections in older people: the role of cranberry products. Age Ageing. 2009;38(3):255–7.
Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2004;(2):CD001321.
Yarnell E. Botanical medicines for the urinary tract. World J Urol. 2002;20(5):285–93.
Foda MM, Middlebrook PF, Gatfield CT, Potvin G, Wells G, Schillinger JF. Efficacy of cranberry in prevention of urinary tract infection in a susceptible pediatric population. Can J Urol. 1995;2(1):98–102.
Fellers CR. Nutritive value of cranberries. Am J Public Health Nations Health. 1933;23(1):13–8.
McLeod DC, Nahata MC. Methenamine therapy and urine acidification with ascorbic acid and cranberry juice. Am J Hosp Pharm. 1978;35(6):654.
Kahn HD, Panariello VA, Saeli J, Sampson JR, Schwartz E. Effect of cranberry juice on urine. J Am Diet Assoc. 1967;51(3):251–4.
Zafriri D, Ofek I, Adar R, Pocino M, Sharon N. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eucaryotic cells. Antimicrob Agents Chemother. 1989;33(1):92–8.
Ofek I, Goldhar J, Sharon N. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. Adv Exp Med Biol. 1996;408:179–83.
Sylvan L, Justice NP. Possible interaction between warfarin and cranberry juice. Am Fam Physician. 2005;72(6):1000; author reply 1000.
Committee on Safety of Medicines MaHPRA. Interaction between warfarin and cranberry juice: new advice. Curr Probl Pharmacovigil. 2004;30:10.
Pham DQ, Pham AQ. Interaction potential between cranberry juice and warfarin. Am J Health Syst Pharm. 2007;64(5):490–4.
Kirby T. Blueberries: shoppers lap up UK’s new superfood. The Independent. Tuesday, 17 May 2005.
Pratt S, Matthews K. SuperFoods Rx: fourteen foods that will change your life. New York: Harper; 2006.
Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol. 1991;85(4):417–25.
Head KA. Natural approaches to prevention and treatment of infections of the lower urinary tract. Altern Med Rev. 2008;13(3):227–44.
Domadia PN, Bhunia A, Sivaraman J, Swarup S, Dasgupta D. Berberine targets assembly of Escherichia coli cell division protein FtsZ. Biochemistry. 2008;47(10):3225–34.
Sun D, Abraham SN, Beachey EH. Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli. Antimicrob Agents Chemother. 1988;32(8):1274–7.
FAO/WHO. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Report of a joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. 2001.
Parkes GC. An overview of probiotics and prebiotics. Nurs Stand. 2007;21(20):43–7.
Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992;14(1):11–6.
Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care. 1994;12(4):239–43.
Reid G, Bruce A, Taylor M. Instillation of Lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther. 1995;23:32–45.
Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322(7302):1571.
Foxman B, Frerichs RR. Epidemiology of urinary tract infection: II. Diet, clothing, and urination habits. Am J Public Health. 1985;75(11):1314–7.
Foxman B, Chi JW. Health behavior and urinary tract infection in college-aged women. J Clin Epidemiol. 1990;43(4):329–37.
Yilmaz A, Bahat E, Yilmaz GG, Hasanoglu A, Akman S, Guven AG. Adjuvant effect of vitamin A on recurrent lower urinary tract infections. Pediatr Int. 2007;49(3):310–3.
Williams G, Craig JC. Prevention of recurrent urinary tract infection in children. Curr Opin Infect Dis. 2009;22(1):72–6.
Spooner JB. Alkalinisation in the management of cystitis. J Int Med Res. 1984;12(1):30–4.
d-Mannose.co.uk. http://www.d-mannose.co.uk/. Last Accessed 27 Sept 2009.
Martinez JJ, Mulvey MA, Schilling JD, Pinkner JS, Hultgren SJ. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 2000;19(12):2803–12.
Hung CS, Bouckaert J, Hung D, Pinkner J, Widberg C, DeFusco A, Auguste CG, Strouse R, Langermann S, Waksman G, Hultgren SJ. Structural basis of tropism of Escherichia coli to the bladder during urinary tract infection. Mol Microbiol. 2002;44(4):903–15.
Alraek T, Soedal LI, Fagerheim SU, Digranes A, Baerheim A. Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health. 2002;92(10):1609–11.
Aune A, Alraek T, LiHua H, Baerheim A. Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care. 1998;16(1):37–9.
Katz AR. Urinary tract infections and acupuncture. Am J Public Health. 2003;93(5):702; author reply 702–3.
Ronald A. Sex and urinary tract infections. N Engl J Med. 1996;335(7):511–2.
Kunin CM, McCormack RC. An epidemiologic study of bacteriuria and blood pressure among nuns and working women. N Engl J Med. 1968;278(12):635–42.
Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE, Stergachis A, Stamm WE. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med. 1996;335(7):468–74.
Remis RS, Gurwith MJ, Gurwith D, Hargrett-Bean NT, Layde PM. Risk factors for urinary tract infection. Am J Epidemiol. 1987;126(4):685–94.
Strom BL, Collins M, West SL, Kreisberg J, Weller S. Sexual activity, contraceptive use, and other risk factors for symptomatic and symptomatic bacteriuria. A case-control study. Ann Intern Med. 1987;107(6):816–23.
Foxman B, Geiger AM, Palin K, Gillespie B, Koopman JS. First-time urinary tract infection and sexual behavior. Epidemiology. 1995;6(2):162–8.
Czaja CA, Stamm WE, Stapleton AE, Roberts PL, Hawn TR, Scholes D, Samadpour M, Hultgren SJ, Hooton TM. Prospective cohort study of microbial and inflammatory events immediately preceding Escherichia coli recurrent urinary tract infection in women. J Infect Dis. 2009;200(4):528–36.
Foxman B, Gillespie B, Koopman J, Zhang L, Palin K, Tallman P, Marsh JV, Spear S, Sobel JD, Marty MJ, Marrs CF. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151(12):1194–205.
Kelsey MC, Mead MG, Gruneberg RN, Oriel JD. Relationship between sexual intercourse and urinary-tract infection in women attending a clinic for sexually transmitted diseases. J Med Microbiol. 1979;12(4):511–2.
Reid G. Potential preventive strategies and therapies in urinary tract infection. World J Urol. 1999;17(6):359–63.
Beetz R. Mild dehydration: a risk factor of urinary tract infection? Eur J Clin Nutr. 2003;57 Suppl 2:S52–8.
Boen JR, Sylwester DL. The mathematical relationship among urinary frequency, residual urine, and bacterial growth in bladder infections. Invest Urol. 1965;2:468–73.
Bailey RR. Management of uncomplicated urinary tract infections. Int J Antimicrob Agents. 1994;4(2):95–100.
Kunin CM. Detection, prevention and management of urinary tract infections. Philadelphia: Lea & Febiger; 1987.
Creighton SM, Stanton SL. Caffeine: does it affect your bladder? Br J Urol. 1990;66(6):613–4.
Vincent C. Symptoms and risk factors associated with a first UTI in college-aged women: a prospective cohort study. AUA. 2009;2009:Abstract 396.
Foxman B, Frerichs RR. Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. Am J Public Health. 1985;75(11):1308–13.
Foxman B, Marsh J, Gillespie B, Rubin N, Koopman JS, Spear S. Condom use and first-time urinary tract infection. Epidemiology. 1997;8(6):637–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Lee, H.A., King, D. (2013). Complementary Therapy Strategies: Myths, Facts, and Lifestyle. In: Rané, A., Dasgupta, R. (eds) Urinary Tract Infection. Springer, London. https://doi.org/10.1007/978-1-4471-4709-1_7
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4709-1_7
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4708-4
Online ISBN: 978-1-4471-4709-1
eBook Packages: MedicineMedicine (R0)